KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) from its SEC filings: 2025 revenue $95.1 million (+59% vs the year before), net margin -138%, free cash flow -$116.6 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $95.1 million |
| Revenue growth | +59% |
| Net income | -$131.6 million |
| Net margin | -138.4% |
| Free cash flow | -$116.6 million |
| Diluted EPS | $-2.43 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +60% |
| Cash | $68.6 million |
| Long-term debt | $72.5 million |
| Share count, 1 year | +16% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.